{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:29:03Z","timestamp":1777580943484,"version":"3.51.4"},"reference-count":150,"publisher":"Journal of Biomedical Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2023]]},"DOI":"10.7555\/jbr.36.20220083","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T08:28:48Z","timestamp":1657960128000},"page":"15","source":"Crossref","is-referenced-by-count":7,"title":["Acquired immunity and Alzheimer's disease"],"prefix":"10.7555","volume":"37","author":[{"given":"Weixi","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.36.20220083-1","doi-asserted-by":"publisher","unstructured":"Alzheimer's Association.  2019 Alzheimer's disease facts and figures[J]. <i>Alzheimers Dement, <\/i>2019, 15(3): 321\u2013387.","DOI":"10.1016\/j.jalz.2019.01.010"},{"key":"key-10.7555\/JBR.36.20220083-2","doi-asserted-by":"publisher","unstructured":"Long JM, Holtzman DM.  Alzheimer disease: an update on pathobiology and treatment strategies[J]. <i>Cell, <\/i>2019, 179(2): 312\u2013339.","DOI":"10.1016\/j.cell.2019.09.001"},{"key":"key-10.7555\/JBR.36.20220083-3","doi-asserted-by":"publisher","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS, et al.  Clearance systems in the brain-implications for Alzheimer disease[J]. <i>Nat Rev Neurol, <\/i>2015, 11(8): 457\u2013470.","DOI":"10.1038\/nrneurol.2015.119"},{"key":"key-10.7555\/JBR.36.20220083-4","doi-asserted-by":"publisher","unstructured":"Xie C, Zhuang X, Niu Z, et al.  Amelioration of Alzheimer's disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow[J]. <i>Nat Biomed Eng, <\/i>2022, 6(1): 76\u201393.","DOI":"10.1038\/s41551-021-00819-5"},{"key":"key-10.7555\/JBR.36.20220083-5","doi-asserted-by":"publisher","unstructured":"Heneka MT, Carson MJ, El Khoury J, et al.  Neuroinflammation in Alzheimer's disease[J]. <i>Lancet Neurol, <\/i>2015, 14(4): 388\u2013405.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"key-10.7555\/JBR.36.20220083-6","doi-asserted-by":"publisher","unstructured":"Ransohoff RM.  How neuroinflammation contributes to neurodegeneration[J]. <i>Science, <\/i>2016, 353(6301): 777\u2013783.","DOI":"10.1126\/science.aag2590"},{"key":"key-10.7555\/JBR.36.20220083-7","doi-asserted-by":"publisher","unstructured":"Fang EF, Hou Y, Palikaras K, et al.  Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer's disease[J]. <i>Nat Neurosci, <\/i>2019, 22(3): 401\u2013412.","DOI":"10.1038\/s41593-018-0332-9"},{"key":"key-10.7555\/JBR.36.20220083-8","doi-asserted-by":"publisher","unstructured":"Lautrup S, Lou G, Aman Y, et al.  Microglial mitophagy mitigates neuroinflammation in Alzheimer's disease[J]. <i>Neurochem Int, <\/i>2019, 129: 104469.","DOI":"10.1016\/j.neuint.2019.104469"},{"key":"key-10.7555\/JBR.36.20220083-9","doi-asserted-by":"publisher","unstructured":"Perry VH, Holmes C.  Microglial priming in neurodegenerative disease[J]. <i>Nat Rev Neurol, <\/i>2014, 10(4): 217\u2013224.","DOI":"10.1038\/nrneurol.2014.38"},{"key":"key-10.7555\/JBR.36.20220083-10","doi-asserted-by":"publisher","unstructured":"Heppner FL, Ransohoff RM, Becher B.  Immune attack: the role of inflammation in Alzheimer disease[J]. <i>Nat Rev Neurosci, <\/i>2015, 16(6): 358\u2013372.","DOI":"10.1038\/nrn3880"},{"key":"key-10.7555\/JBR.36.20220083-11","doi-asserted-by":"publisher","unstructured":"Heneka MT, Kummer MP, Latz E.  Innate immune activation in neurodegenerative disease[J]. <i>Nat Rev Immunol, <\/i>2014, 14(7): 463\u2013477.","DOI":"10.1038\/nri3705"},{"key":"key-10.7555\/JBR.36.20220083-12","doi-asserted-by":"publisher","unstructured":"Villegas-Llerena C, Phillips A, Garcia-Reitboeck P, et al.  Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease[J]. <i>Curr Opin Neurobiol, <\/i>2016, 36: 74\u201381.","DOI":"10.1016\/j.conb.2015.10.004"},{"key":"key-10.7555\/JBR.36.20220083-13","doi-asserted-by":"publisher","unstructured":"Salter MW, Stevens B.  Microglia emerge as central players in brain disease[J]. <i>Nat Med, <\/i>2017, 23(9): 1018\u20131027.","DOI":"10.1038\/nm.4397"},{"key":"key-10.7555\/JBR.36.20220083-14","doi-asserted-by":"publisher","unstructured":"Efthymiou AG, Goate AM.  Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk[J]. <i>Mol Neurodegener, <\/i>2017, 12(1): 43.","DOI":"10.1186\/s13024-017-0184-x"},{"key":"key-10.7555\/JBR.36.20220083-15","doi-asserted-by":"publisher","unstructured":"Mhatre SD, Tsai CA, Rubin AJ, et al.  Microglial malfunction: the third rail in the development of Alzheimer's disease[J]. <i>Trends Neurosci, <\/i>2015, 38(10): 621\u2013636.","DOI":"10.1016\/j.tins.2015.08.006"},{"key":"key-10.7555\/JBR.36.20220083-16","doi-asserted-by":"publisher","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, et al.  A unique microglia type associated with restricting development of Alzheimer's disease[J]. <i>Cell, <\/i>2017, 169(7): 1276\u20131290.e17.","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"key-10.7555\/JBR.36.20220083-17","doi-asserted-by":"publisher","unstructured":"Zewinger S, Reiser J, Jankowski V, et al.  Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation[J]. <i>Nat Immunol, <\/i>2020, 21(1): 30\u201341.","DOI":"10.1038\/s41590-019-0548-1"},{"key":"key-10.7555\/JBR.36.20220083-18","doi-asserted-by":"publisher","unstructured":"Osborn LM, Kamphuis W, Wadman WJ, et al.  Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease[J]. <i>Prog Neurobiol, <\/i>2016, 144: 121\u2013141.","DOI":"10.1016\/j.pneurobio.2016.01.001"},{"key":"key-10.7555\/JBR.36.20220083-19","doi-asserted-by":"publisher","unstructured":"Bradshaw EM, Chibnik LB, Keenan BT, et al. <i>CD33<\/i> Alzheimer's disease locus: altered monocyte function and amyloid biology[J]. <i>Nat Neurosci, <\/i>2013, 16(7): 848\u2013850.","DOI":"10.1038\/nn.3435"},{"key":"key-10.7555\/JBR.36.20220083-20","doi-asserted-by":"publisher","unstructured":"Bettens K, Sleegers K, Van Broeckhoven C.  Genetic insights in Alzheimer's disease[J]. <i>Lancet Neurol, <\/i>2013, 12(1): 92\u2013104.","DOI":"10.1016\/S1474-4422(12)70259-4"},{"key":"key-10.7555\/JBR.36.20220083-21","doi-asserted-by":"publisher","unstructured":"Deming Y, Filipello F, Cignarella F, et al.  The <i>MS4A<\/i> gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk[J]. <i>Sci Transl Med, <\/i>2019, 11(505): eaau2291.","DOI":"10.1126\/scitranslmed.aau2291"},{"key":"key-10.7555\/JBR.36.20220083-22","doi-asserted-by":"publisher","unstructured":"Cuyvers E, Sleegers K.  Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond[J]. <i>Lancet Neurol, <\/i>2016, 15(8): 857\u2013868.","DOI":"10.1016\/S1474-4422(16)00127-7"},{"key":"key-10.7555\/JBR.36.20220083-23","doi-asserted-by":"publisher","unstructured":"Yuan P, Condello C, Keene CD, et al.  TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy[J]. <i>Neuron, <\/i>2016, 90(4): 724\u2013739.","DOI":"10.1016\/j.neuron.2016.05.003"},{"key":"key-10.7555\/JBR.36.20220083-24","doi-asserted-by":"publisher","unstructured":"Su\u00e1rez-Calvet M, Araque Caballero M\u00c1, Kleinberger G, et al.  Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury[J]. <i>Sci Transl Med, <\/i>2016, 8(369): 369ra178.","DOI":"10.1126\/scitranslmed.aag1767"},{"key":"key-10.7555\/JBR.36.20220083-25","doi-asserted-by":"publisher","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, et al.  Complement and microglia mediate early synapse loss in Alzheimer mouse models[J]. <i>Science, <\/i>2016, 352(6286): 712\u2013716.","DOI":"10.1126\/science.aad8373"},{"key":"key-10.7555\/JBR.36.20220083-26","doi-asserted-by":"publisher","unstructured":"Riazi K, Galic MA, Kentner AC, et al.  Microglia-dependent alteration of glutamatergic synaptic transmission and plasticity in the hippocampus during peripheral inflammation[J]. <i>J Neurosci, <\/i>2015, 35(12): 4942\u20134952.","DOI":"10.1523\/JNEUROSCI.4485-14.2015"},{"key":"key-10.7555\/JBR.36.20220083-27","doi-asserted-by":"publisher","unstructured":"Zhang J, Malik A, Choi HB, et al.  Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase[J]. <i>Neuron, <\/i>2014, 82(1): 195\u2013207.","DOI":"10.1016\/j.neuron.2014.01.043"},{"key":"key-10.7555\/JBR.36.20220083-28","doi-asserted-by":"publisher","unstructured":"Lau SF, Chen C, Fu W, et al.  IL-33-PU.1 Transcriptome reprogramming drives functional state transition and clearance activity of microglia in alzheimer's disease[J]. <i>Cell Rep, <\/i>2020, 31(3): 107530.","DOI":"10.1016\/j.celrep.2020.107530"},{"key":"key-10.7555\/JBR.36.20220083-29","doi-asserted-by":"publisher","unstructured":"Huang K, Marcora E, Pimenova AA, et al.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease[J]. <i>Nat Neurosci, <\/i>2017, 20(8): 1052\u20131061.","DOI":"10.1038\/nn.4587"},{"key":"key-10.7555\/JBR.36.20220083-30","doi-asserted-by":"publisher","unstructured":"Iliff JJ, Wang M, Liao Y, et al.  A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2[J]. <i>Sci Transl Med, <\/i>2012, 4(147): 147ra111.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"key-10.7555\/JBR.36.20220083-31","doi-asserted-by":"publisher","unstructured":"Aspelund A, Antila S, Proulx ST, et al.  A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules[J]. <i>J Exp Med, <\/i>2015, 212(7): 991\u2013999.","DOI":"10.1084\/jem.20142290"},{"key":"key-10.7555\/JBR.36.20220083-32","doi-asserted-by":"publisher","unstructured":"Mestre H, Hablitz LM, Xavier AL, et al.  Aquaporin-4-dependent glymphatic solute transport in the rodent brain[J]. <i>Elife, <\/i>2018, 7: e40070.","DOI":"10.7554\/eLife.40070"},{"key":"key-10.7555\/JBR.36.20220083-33","doi-asserted-by":"publisher","unstructured":"Ahn JH, Cho H, Kim JH, et al.  Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid[J]. <i>Nature, <\/i>2019, 572(7767): 62\u201366.","DOI":"10.1038\/s41586-019-1419-5"},{"key":"key-10.7555\/JBR.36.20220083-34","doi-asserted-by":"publisher","unstructured":"Louveau A, Smirnov I, Keyes TJ, et al.  Structural and functional features of central nervous system lymphatic vessels[J]. <i>Nature, <\/i>2015, 523(7560): 337\u2013341.","DOI":"10.1038\/nature14432"},{"key":"key-10.7555\/JBR.36.20220083-35","doi-asserted-by":"publisher","unstructured":"Wang L, Zhang Y, Zhao Y, et al.  Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice[J]. <i>Brain Pathol, <\/i>2019, 29(2): 176\u2013192.","DOI":"10.1111\/bpa.12656"},{"key":"key-10.7555\/JBR.36.20220083-36","doi-asserted-by":"publisher","unstructured":"Da Mesquita S, Louveau A, Vaccari A, et al.  Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease[J]. <i>Nature, <\/i>2018, 560(7717): 185\u2013191.","DOI":"10.1038\/s41586-018-0368-8"},{"key":"key-10.7555\/JBR.36.20220083-37","doi-asserted-by":"publisher","unstructured":"Xu Z, Xiao N, Chen Y, et al.  Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits[J]. <i>Mol Neurodegener, <\/i>2015, 10: 58.","DOI":"10.1186\/s13024-015-0056-1"},{"key":"key-10.7555\/JBR.36.20220083-38","doi-asserted-by":"publisher","unstructured":"Peng W, Achariyar TM, Li B, et al.  Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease[J]. <i>Neurobiol Dis, <\/i>2016, 93: 215\u2013225.","DOI":"10.1016\/j.nbd.2016.05.015"},{"key":"key-10.7555\/JBR.36.20220083-39","doi-asserted-by":"publisher","unstructured":"Busse M, Michler E, von Hoff F, et al.  Alterations in the peripheral immune system in dementia[J]. <i>J Alzheimers Dis, <\/i>2017, 58(4): 1303\u20131313.","DOI":"10.3233\/JAD-161304"},{"key":"key-10.7555\/JBR.36.20220083-40","doi-asserted-by":"publisher","unstructured":"Richartz-Salzburger E, Batra A, Stransky E, et al.  Altered lymphocyte distribution in Alzheimer's disease[J]. <i>J Psychiatr Res, <\/i>2007, 41(1-2): 174\u2013178.","DOI":"10.1016\/j.jpsychires.2006.01.010"},{"key":"key-10.7555\/JBR.36.20220083-41","doi-asserted-by":"publisher","unstructured":"Pellican\u00f2 M, Larbi A, Goldeck D, et al.  Immune profiling of Alzheimer patients[J]. <i>J Neuroimmunol, <\/i>2012, 242(1-2): 52\u201359.","DOI":"10.1016\/j.jneuroim.2011.11.005"},{"key":"key-10.7555\/JBR.36.20220083-42","doi-asserted-by":"publisher","unstructured":"Bulati M, Buffa S, Martorana A, et al.  Double negative (IgG<sup>+<\/sup>IgD<sup>-<\/sup>CD27<sup>-<\/sup>) B cells are increased in a cohort of moderate-severe Alzheimer's disease patients and show a pro-inflammatory trafficking receptor phenotype[J]. <i>J Alzheimers Dis, <\/i>2015, 44(4): 1241\u20131251.","DOI":"10.3233\/JAD-142412"},{"key":"key-10.7555\/JBR.36.20220083-43","doi-asserted-by":"publisher","unstructured":"Bonotis K, Krikki E, Holeva V, et al.  Systemic immune aberrations in Alzheimer's disease patients[J]. <i>J Neuroimmunol, <\/i>2008, 193(1-2): 183\u2013187.","DOI":"10.1016\/j.jneuroim.2007.10.020"},{"key":"key-10.7555\/JBR.36.20220083-44","doi-asserted-by":"publisher","unstructured":"Speciale L, Calabrese E, Saresella M, et al.  Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients[J]. <i>Neurobiol Aging, <\/i>2007, 28(8): 1163\u20131169.","DOI":"10.1016\/j.neurobiolaging.2006.05.020"},{"key":"key-10.7555\/JBR.36.20220083-45","doi-asserted-by":"publisher","unstructured":"Larbi A, Pawelec G, Witkowski JM, et al.  Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease[J]. <i>J Alzheimers Dis, <\/i>2009, 17(1): 91\u2013103.","DOI":"10.3233\/JAD-2009-1015"},{"key":"key-10.7555\/JBR.36.20220083-46","doi-asserted-by":"publisher","unstructured":"Bulati M, Buffa S, Candore G, et al.  B cells and immunosenescence: a focus on IgG<sup>+<\/sup>IgD<sup>-<\/sup>CD27<sup>-<\/sup> (DN) B cells in aged humans[J]. <i>Ageing Res Rev, <\/i>2011, 10(2): 274\u2013284.","DOI":"10.1016\/j.arr.2010.12.002"},{"key":"key-10.7555\/JBR.36.20220083-47","doi-asserted-by":"publisher","unstructured":"Steele NZR, Carr JS, Bonham LW, et al.  Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: a case-control study[J]. <i>PLoS Med, <\/i>2017, 14(3): e1002272.","DOI":"10.1371\/journal.pmed.1002272"},{"key":"key-10.7555\/JBR.36.20220083-48","doi-asserted-by":"publisher","unstructured":"Jiang Q, Jin S, Jiang Y, et al.  Alzheimer's disease variants with the genome-wide significance are significantly enriched in immune pathways and active in immune cells[J]. <i>Mol Neurobiol, <\/i>2017, 54(1): 594\u2013600.","DOI":"10.1007\/s12035-015-9670-8"},{"key":"key-10.7555\/JBR.36.20220083-49","doi-asserted-by":"publisher","unstructured":"Gate D, Saligrama N, Leventhal O, et al.  Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease[J]. <i>Nature, <\/i>2020, 577(7790): 399\u2013404.","DOI":"10.1038\/s41586-019-1895-7"},{"key":"key-10.7555\/JBR.36.20220083-50","doi-asserted-by":"publisher","unstructured":"Engelhardt B, Ransohoff RM.  The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms[J]. <i>Trends Immunol, <\/i>2005, 26(9): 485\u2013495.","DOI":"10.1016\/j.it.2005.07.004"},{"key":"key-10.7555\/JBR.36.20220083-51","doi-asserted-by":"publisher","unstructured":"Siffrin V, Brandt AU, Radbruch H, et al.  Differential immune cell dynamics in the CNS cause CD4<sup>+<\/sup> T cell compartmentalization[J]. <i>Brain, <\/i>2009, 132(Pt 5): 1247\u20131258.","DOI":"10.1093\/brain\/awn354"},{"key":"key-10.7555\/JBR.36.20220083-52","doi-asserted-by":"publisher","unstructured":"Pranzatelli MR, Allison TJ, McGee NR, et al.  Cerebrospinal fluid \u03b3\u03b4 T cell frequency is age-related: a case-control study of 435 children with inflammatory and non-inflammatory neurological disorders[J]. <i>Clin Exp Immunol, <\/i>2018, 193(1): 103\u2013112.","DOI":"10.1111\/cei.13122"},{"key":"key-10.7555\/JBR.36.20220083-53","doi-asserted-by":"publisher","unstructured":"Cheng X, He P, Yao H, et al.  Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy[J]. <i>Neurology, <\/i>2014, 82(19): 1707\u20131715.","DOI":"10.1212\/WNL.0000000000000403"},{"key":"key-10.7555\/JBR.36.20220083-54","doi-asserted-by":"publisher","unstructured":"Carrano A, Hoozemans JJM, van der Vies SM, et al.  Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy[J]. <i>Antioxid Redox Signal, <\/i>2011, 15(5): 1167\u20131178.","DOI":"10.1089\/ars.2011.3895"},{"key":"key-10.7555\/JBR.36.20220083-55","doi-asserted-by":"publisher","unstructured":"Liu Y, Guo D, Tian L, et al.  Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-\u03b1-dependent[J]. <i>Neurobiol Aging, <\/i>2010, 31(2): 175\u2013188.","DOI":"10.1016\/j.neurobiolaging.2008.03.024"},{"key":"key-10.7555\/JBR.36.20220083-56","doi-asserted-by":"publisher","unstructured":"Kerfoot SM, Kubes P.  Overlapping roles of P-selectin and \u03b1<sub>4<\/sub> integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis[J]. <i>J Immunol, <\/i>2002, 169(2): 1000\u20131006.","DOI":"10.4049\/jimmunol.169.2.1000"},{"key":"key-10.7555\/JBR.36.20220083-57","doi-asserted-by":"publisher","unstructured":"Reboldi A, Coisne C, Baumjohann D, et al.  C-C chemokine receptor 6-regulated entry of T<sub>H<\/sub>-17 cells into the CNS through the choroid plexus is required for the initiation of EAE[J]. <i>Nat Immunol, <\/i>2009, 10(5): 514\u2013523.","DOI":"10.1038\/ni.1716"},{"key":"key-10.7555\/JBR.36.20220083-58","doi-asserted-by":"publisher","unstructured":"Laurent C, Doroth\u00e9e G, Hunot S, et al.  Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy[J]. <i>Brain, <\/i>2017, 140(1): 184\u2013200.","DOI":"10.1093\/brain\/aww270"},{"key":"key-10.7555\/JBR.36.20220083-59","doi-asserted-by":"publisher","unstructured":"Smolders J, Remmerswaal EBM, Schuurman KG, et al.  Characteristics of differentiated CD8<sup>+<\/sup> and CD4<sup>+<\/sup> T cells present in the human brain[J]. <i>Acta Neuropathol, <\/i>2013, 126(4): 525\u2013535.","DOI":"10.1007\/s00401-013-1155-0"},{"key":"key-10.7555\/JBR.36.20220083-60","doi-asserted-by":"publisher","unstructured":"Togo T, Akiyama H, Iseki E, et al.  Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases[J]. <i>J Neuroimmunol, <\/i>2002, 124(1-2): 83\u201392.","DOI":"10.1016\/S0165-5728(01)00496-9"},{"key":"key-10.7555\/JBR.36.20220083-61","doi-asserted-by":"publisher","unstructured":"Agrawal S, Anderson P, Durbeej M, et al.  Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis[J]. <i>J Exp Med, <\/i>2006, 203(4): 1007\u20131019.","DOI":"10.1084\/jem.20051342"},{"key":"key-10.7555\/JBR.36.20220083-62","doi-asserted-by":"publisher","unstructured":"Song J, Wu C, Korpos E, et al.  Focal MMP-2 and MMP-9 activity at the blood-brain barrier promotes chemokine-induced leukocyte migration[J]. <i>Cell Rep, <\/i>2015, 10(7): 1040\u20131054.","DOI":"10.1016\/j.celrep.2015.01.037"},{"key":"key-10.7555\/JBR.36.20220083-63","doi-asserted-by":"publisher","unstructured":"Betsholtz C.  Physiology: double function at the blood-brain barrier[J]. <i>Nature, <\/i>2014, 509(7501): 432\u2013433.","DOI":"10.1038\/nature13339"},{"key":"key-10.7555\/JBR.36.20220083-64","doi-asserted-by":"publisher","unstructured":"Kook SY, Seok Hong H, Moon M, et al.  Disruption of blood-brain barrier in Alzheimer disease pathogenesis[J]. <i>Tissue Barriers, <\/i>2013, 1(2): e23993.","DOI":"10.4161\/tisb.23993"},{"key":"key-10.7555\/JBR.36.20220083-65","doi-asserted-by":"publisher","unstructured":"Stamatovic SM, Martinez-Revollar G, Hu A, et al.  Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging[J]. <i>Neurobiol Dis, <\/i>2019, 126: 105\u2013116.","DOI":"10.1016\/j.nbd.2018.09.006"},{"key":"key-10.7555\/JBR.36.20220083-66","doi-asserted-by":"publisher","unstructured":"Shechter R, London A, Schwartz M.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates[J]. <i>Nat Rev Immunol, <\/i>2013, 13(3): 206\u2013218.","DOI":"10.1038\/nri3391"},{"key":"key-10.7555\/JBR.36.20220083-67","doi-asserted-by":"publisher","unstructured":"Engelhardt B, Wolburg-Buchholz K, Wolburg H.  Involvement of the choroid plexus in central nervous system inflammation[J]. <i>Microsc Res Tech, <\/i>2001, 52(1): 112\u2013129.","DOI":"10.1002\/1097-0029(20010101)52:1<112::AID-JEMT13>3.0.CO;2-5"},{"key":"key-10.7555\/JBR.36.20220083-68","doi-asserted-by":"publisher","unstructured":"Choi JD, Moon Y, Kim HJ, et al.  Choroid plexus volume and permeability at brain MRI within the alzheimer disease clinical spectrum[J]. <i>Radiology, <\/i>2022, 212400.","DOI":"10.1148\/radiol.212400"},{"key":"key-10.7555\/JBR.36.20220083-69","doi-asserted-by":"publisher","unstructured":"Vargas T, Ugalde C, Spuch C, et al.  A\u03b2 accumulation in choroid plexus is associated with mitochondrial-induced apoptosis[J]. <i>Neurobiol Aging, <\/i>2010, 31(9): 1569\u20131581.","DOI":"10.1016\/j.neurobiolaging.2008.08.017"},{"key":"key-10.7555\/JBR.36.20220083-70","doi-asserted-by":"publisher","unstructured":"Brkic M, Balusu S, Van Wonterghem E, et al.  Amyloid \u03b2 oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases[J]. <i>J Neurosci, <\/i>2015, 35(37): 12766\u201312778.","DOI":"10.1523\/JNEUROSCI.0006-15.2015"},{"key":"key-10.7555\/JBR.36.20220083-71","doi-asserted-by":"publisher","unstructured":"Schl\u00e4ger C, K\u00f6rner H, Krueger M, et al.  Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid[J]. <i>Nature, <\/i>2016, 530(7590): 349\u2013353.","DOI":"10.1038\/nature16939"},{"key":"key-10.7555\/JBR.36.20220083-72","doi-asserted-by":"publisher","unstructured":"Roth TL, Nayak D, Atanasijevic T, et al.  Transcranial amelioration of inflammation and cell death after brain injury[J]. <i>Nature, <\/i>2014, 505(7482): 223\u2013228.","DOI":"10.1038\/nature12808"},{"key":"key-10.7555\/JBR.36.20220083-73","doi-asserted-by":"publisher","unstructured":"Barker CF, Billingham RE.  The role of afferent lymphatics in the rejection of skin homografts[J]. <i>J Exp Med, <\/i>1968, 128(1): 197\u2013221.","DOI":"10.1084\/jem.128.1.197"},{"key":"key-10.7555\/JBR.36.20220083-74","doi-asserted-by":"publisher","unstructured":"Ransohoff RM, Engelhardt B.  The anatomical and cellular basis of immune surveillance in the central nervous system[J]. <i>Nat Rev Immunol, <\/i>2012, 12(9): 623\u2013635.","DOI":"10.1038\/nri3265"},{"key":"key-10.7555\/JBR.36.20220083-75","doi-asserted-by":"publisher","unstructured":"Louveau A, Herz J, Alme MN, et al.  CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature[J]. <i>Nat Neurosci, <\/i>2018, 21(10): 1380\u20131391.","DOI":"10.1038\/s41593-018-0227-9"},{"key":"key-10.7555\/JBR.36.20220083-76","doi-asserted-by":"publisher","unstructured":"Rogers J, Luber-Narod J, Styren SD, et al.  Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease[J]. <i>Neurobiol Aging, <\/i>1988, 9(4): 339\u2013349.","DOI":"10.1016\/S0197-4580(88)80079-4"},{"key":"key-10.7555\/JBR.36.20220083-77","doi-asserted-by":"publisher","unstructured":"Sardi F, Fassina L, Venturini L, et al.  Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly[J]. <i>Autoimmun Rev, <\/i>2011, 11(2): 149\u2013153.","DOI":"10.1016\/j.autrev.2011.09.005"},{"key":"key-10.7555\/JBR.36.20220083-78","doi-asserted-by":"publisher","unstructured":"Monsonego A, Zota V, Karni A, et al.  Increased T cell reactivity to amyloid \u03b2 protein in older humans and patients with Alzheimer disease[J]. <i>J Clin Invest, <\/i>2003, 112(3): 415\u2013422.","DOI":"10.1172\/JCI200318104"},{"key":"key-10.7555\/JBR.36.20220083-79","doi-asserted-by":"publisher","unstructured":"Browne TC, McQuillan K, McManus RM, et al.  IFN-\u03b3 production by amyloid \u03b2-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease[J]. <i>J Immunol, <\/i>2013, 190(5): 2241\u20132251.","DOI":"10.4049\/jimmunol.1200947"},{"key":"key-10.7555\/JBR.36.20220083-80","doi-asserted-by":"publisher","unstructured":"Fisher Y, Strominger I, Biton S, et al.  Th1 polarization of T cells injected into the cerebrospinal fluid induces brain immunosurveillance[J]. <i>J Immunol, <\/i>2014, 192(1): 92\u2013102.","DOI":"10.4049\/jimmunol.1301707"},{"key":"key-10.7555\/JBR.36.20220083-81","doi-asserted-by":"publisher","unstructured":"Cao C, Arendash GW, Dickson A, et al.  A\u03b2-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS[J]. <i>Neurobiol Dis, <\/i>2009, 34(1): 63\u201370.","DOI":"10.1016\/j.nbd.2008.12.015"},{"key":"key-10.7555\/JBR.36.20220083-82","doi-asserted-by":"publisher","unstructured":"Asuni AA, Boutajangout A, Scholtzova H, et al.  Vaccination of Alzheimer's model mice with A\u03b2 derivative in alum adjuvant reduces A\u03b2 burden without microhemorrhages[J]. <i>Eur J Neurosci, <\/i>2006, 24(9): 2530\u20132542.","DOI":"10.1111\/j.1460-9568.2006.05149.x"},{"key":"key-10.7555\/JBR.36.20220083-83","doi-asserted-by":"publisher","unstructured":"Lambracht-Washington D, Qu B, Fu M, et al.  DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation[J]. <i>Cell Mol Neurobiol, <\/i>2011, 31(6): 867\u2013874.","DOI":"10.1007\/s10571-011-9680-7"},{"key":"key-10.7555\/JBR.36.20220083-84","doi-asserted-by":"publisher","unstructured":"Fu H, Liu B, Frost JL, et al.  Amyloid-\u03b2 immunotherapy for Alzheimer's disease[J]. <i>CNS Neurol Disord Drug Targets, <\/i>2010, 9(2): 197\u2013206.","DOI":"10.2174\/187152710791012017"},{"key":"key-10.7555\/JBR.36.20220083-85","doi-asserted-by":"publisher","unstructured":"Goldeck D, Larbi A, Pellican\u00f3 M, et al.  Enhanced chemokine receptor expression on leukocytes of patients with Alzheimer's disease[J]. <i>PLoS One, <\/i>2013, 8(6): e66664.","DOI":"10.1371\/journal.pone.0066664"},{"key":"key-10.7555\/JBR.36.20220083-86","doi-asserted-by":"publisher","unstructured":"Zhang J, Ke K, Liu Z, et al.  Th17 cell-mediated neuroinflammation is involved in neurodegeneration of A\u03b2<sub>1\u201342<\/sub>-induced Alzheimer's disease model rats[J]. <i>PLoS One, <\/i>2013, 8(10): e75786.","DOI":"10.1371\/journal.pone.0075786"},{"key":"key-10.7555\/JBR.36.20220083-87","doi-asserted-by":"publisher","unstructured":"Jones JL, Anderson JM, Phuah CL, et al.  Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity[J]. <i>Brain, <\/i>2010, 133(Pt 8): 2232\u20132247.","DOI":"10.1093\/brain\/awq176"},{"key":"key-10.7555\/JBR.36.20220083-88","doi-asserted-by":"publisher","unstructured":"Alves S, Churlaud G, Audrain M, et al.  Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice[J]. <i>Brain, <\/i>2017, 140(3): 826\u2013842.","DOI":"10.1093\/brain\/aww330"},{"key":"key-10.7555\/JBR.36.20220083-89","doi-asserted-by":"publisher","unstructured":"Dansokho C, Ait Ahmed D, Aid S, et al.  Regulatory T cells delay disease progression in Alzheimer-like pathology[J]. <i>Brain, <\/i>2016, 139(Pt 4): 1237\u20131251.","DOI":"10.1093\/brain\/awv408"},{"key":"key-10.7555\/JBR.36.20220083-90","doi-asserted-by":"publisher","unstructured":"Di Liberto G, Pantelyushin S, Kreutzfeldt M, et al.  Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping[J]. <i>Cell, <\/i>2018, 175(2): 458\u2013471.e19.","DOI":"10.1016\/j.cell.2018.07.049"},{"key":"key-10.7555\/JBR.36.20220083-91","doi-asserted-by":"publisher","unstructured":"Mattsson N, Andreasson U, Zetterberg H, et al.  Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease[J]. <i>JAMA Neurol, <\/i>2017, 74(5): 557\u2013566.","DOI":"10.1001\/jamaneurol.2016.6117"},{"key":"key-10.7555\/JBR.36.20220083-92","doi-asserted-by":"publisher","unstructured":"Preische O, Schultz SA, Apel A, et al.  Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease[J]. <i>Nat Med, <\/i>2019, 25(2): 277\u2013283.","DOI":"10.1038\/s41591-018-0304-3"},{"key":"key-10.7555\/JBR.36.20220083-93","doi-asserted-by":"publisher","unstructured":"Krishnamoorthy G, Saxena A, Mars LT, et al.  Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis[J]. <i>Nat Med, <\/i>2009, 15(6): 626\u2013632.","DOI":"10.1038\/nm.1975"},{"key":"key-10.7555\/JBR.36.20220083-94","doi-asserted-by":"publisher","unstructured":"McQuillan K, Lynch MA, Mills KHG.  Activation of mixed glia by A\u03b2-specific Th1 and Th17 cells and its regulation by Th2 cells[J]. <i>Brain Behav Immun, <\/i>2010, 24(4): 598\u2013607.","DOI":"10.1016\/j.bbi.2010.01.003"},{"key":"key-10.7555\/JBR.36.20220083-95","doi-asserted-by":"publisher","unstructured":"Takahashi K, Rochford CDP, Neumann H.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2[J]. <i>J Exp Med, <\/i>2005, 201(4): 647\u2013657.","DOI":"10.1084\/jem.20041611"},{"key":"key-10.7555\/JBR.36.20220083-96","doi-asserted-by":"publisher","unstructured":"Gaikwad S, Larionov S, Wang Y, et al.  Signal regulatory protein-\u03b21: a microglial modulator of phagocytosis in Alzheimer's disease[J]. <i>Am J Pathol, <\/i>2009, 175(6): 2528\u20132539.","DOI":"10.2353\/ajpath.2009.090147"},{"key":"key-10.7555\/JBR.36.20220083-97","doi-asserted-by":"publisher","unstructured":"Obregon D, Hou H, Bai Y, et al.  CD40L disruption enhances A\u03b2 vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation[J]. <i>Neurobiol Dis, <\/i>2008, 29(2): 336\u2013353.","DOI":"10.1016\/j.nbd.2007.09.009"},{"key":"key-10.7555\/JBR.36.20220083-98","doi-asserted-by":"publisher","unstructured":"Le Blon D, Guglielmetti C, Hoornaert C, et al.  Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model[J]. <i>J Neuroinflammation, <\/i>2016, 13(1): 288.","DOI":"10.1186\/s12974-016-0756-7"},{"key":"key-10.7555\/JBR.36.20220083-99","doi-asserted-by":"publisher","unstructured":"Guarda G, Dostert C, Staehli F, et al.  T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes[J]. <i>Nature, <\/i>2009, 460(7252): 269\u2013273.","DOI":"10.1038\/nature08100"},{"key":"key-10.7555\/JBR.36.20220083-100","doi-asserted-by":"publisher","unstructured":"Garg SK, Banerjee R, Kipnis J.  Neuroprotective immunity: T cell-derived glutamate endows astrocytes with a neuroprotective phenotype[J]. <i>J Immunol, <\/i>2008, 180(6): 3866\u20133873.","DOI":"10.4049\/jimmunol.180.6.3866"},{"key":"key-10.7555\/JBR.36.20220083-101","doi-asserted-by":"publisher","unstructured":"Beurel E, Harrington LE, Buchser W, et al.  Astrocytes modulate the polarization of CD4<sup>+<\/sup> T cells to Th1 cells[J]. <i>PLoS One, <\/i>2014, 9(1): e86257.","DOI":"10.1371\/journal.pone.0086257"},{"key":"key-10.7555\/JBR.36.20220083-102","doi-asserted-by":"publisher","unstructured":"Xie L, Choudhury GR, Winters A, et al.  Cerebral regulatory T cells restrain microglia\/macrophage-mediated inflammatory responses via IL-10[J]. <i>Eur J Immunol, <\/i>2015, 45(1): 180\u2013191.","DOI":"10.1002\/eji.201444823"},{"key":"key-10.7555\/JBR.36.20220083-103","doi-asserted-by":"publisher","unstructured":"Dombrowski Y, O'Hagan T, Dittmer M, et al.  Regulatory T cells promote myelin regeneration in the central nervous system[J]. <i>Nat Neurosci, <\/i>2017, 20(5): 674\u2013680.","DOI":"10.1038\/nn.4528"},{"key":"key-10.7555\/JBR.36.20220083-104","doi-asserted-by":"publisher","unstructured":"Aloisi F, De Simone R, Columba-Cabezas S, et al.  Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells[J]. <i>J Immunol, <\/i>2000, 164(4): 1705\u20131712.","DOI":"10.4049\/jimmunol.164.4.1705"},{"key":"key-10.7555\/JBR.36.20220083-105","doi-asserted-by":"publisher","unstructured":"Das Sarma J, Ciric B, Marek R, et al.  Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis[J]. <i>J Neuroinflammation, <\/i>2009, 6: 14.","DOI":"10.1186\/1742-2094-6-14"},{"key":"key-10.7555\/JBR.36.20220083-106","doi-asserted-by":"publisher","unstructured":"Rock RB, Hu S, Deshpande A, et al.  Transcriptional response of human microglial cells to interferon-\u03b3[J]. <i>Genes Immun, <\/i>2005, 6(8): 712\u2013719.","DOI":"10.1038\/sj.gene.6364246"},{"key":"key-10.7555\/JBR.36.20220083-107","doi-asserted-by":"publisher","unstructured":"Togo T, Akiyama H, Kondo H, et al.  Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases[J]. <i>Brain Res, <\/i>2000, 885(1): 117\u2013121.","DOI":"10.1016\/S0006-8993(00)02984-X"},{"key":"key-10.7555\/JBR.36.20220083-108","doi-asserted-by":"publisher","unstructured":"Townsend KP, Town T, Mori T, et al.  CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid \u03b2-peptide[J]. <i>Eur J Immunol, <\/i>2005, 35(3): 901\u2013910.","DOI":"10.1002\/eji.200425585"},{"key":"key-10.7555\/JBR.36.20220083-109","doi-asserted-by":"publisher","unstructured":"McManus RM, Mills KHG, Lynch MA.  T cells-protective or pathogenic in Alzheimer's disease?[J]. <i>J Neuroimmune Pharmacol, <\/i>2015, 10(4): 547\u2013560.","DOI":"10.1007\/s11481-015-9612-2"},{"key":"key-10.7555\/JBR.36.20220083-110","doi-asserted-by":"publisher","unstructured":"Zeinstra E, Wilczak N, De Keyser J.  Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7\u20131 and B7\u20132[J]. <i>J Neuroimmunol, <\/i>2003, 135(1-2): 166\u2013171.","DOI":"10.1016\/S0165-5728(02)00462-9"},{"key":"key-10.7555\/JBR.36.20220083-111","doi-asserted-by":"publisher","unstructured":"Yang J, Kou J, Lalonde R, et al.  Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease[J]. <i>Brain Behav Immun, <\/i>2017, 65: 262\u2013273.","DOI":"10.1016\/j.bbi.2017.05.012"},{"key":"key-10.7555\/JBR.36.20220083-112","doi-asserted-by":"publisher","unstructured":"Weiss R, Lifshitz V, Frenkel D.  TGF-\u03b21 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis[J]. <i>Brain Behav Immun, <\/i>2011, 25(5): 1017\u20131024.","DOI":"10.1016\/j.bbi.2010.11.012"},{"key":"key-10.7555\/JBR.36.20220083-113","doi-asserted-by":"publisher","unstructured":"Man S, Ma Y, Shang D, et al.  Peripheral T cells overexpress MIP-1\u03b1 to enhance its transendothelial migration in Alzheimer's disease[J]. <i>Neurobiol Aging, <\/i>2007, 28(4): 485\u2013496.","DOI":"10.1016\/j.neurobiolaging.2006.02.013"},{"key":"key-10.7555\/JBR.36.20220083-114","doi-asserted-by":"publisher","unstructured":"Pietronigro E, Zenaro E, Bianca VD, et al.  Blockade of \u03b14 integrins reduces leukocyte-endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer's disease[J]. <i>Sci Rep, <\/i>2019, 9(1): 12055.","DOI":"10.1038\/s41598-019-48538-x"},{"key":"key-10.7555\/JBR.36.20220083-115","doi-asserted-by":"publisher","unstructured":"Hamza TH, Zabetian CP, Tenesa A, et al.  Common genetic variation in the <i>HLA<\/i> region is associated with late-onset sporadic Parkinson's disease[J]. <i>Nat Genet, <\/i>2010, 42(9): 781\u2013785.","DOI":"10.1038\/ng.642"},{"key":"key-10.7555\/JBR.36.20220083-116","doi-asserted-by":"publisher","unstructured":"Fuller JP, Stavenhagen JB, Teeling JL.  New roles for Fc receptors in neurodegeneration-the impact on Immunotherapy for Alzheimer's Disease[J]. <i>Front Neurosci, <\/i>2014, 8: 235.","DOI":"10.3389\/fnins.2014.00235"},{"key":"key-10.7555\/JBR.36.20220083-117","doi-asserted-by":"publisher","unstructured":"Piazza F, Greenberg SM, Savoiardo M, et al.  Anti-amyloid \u03b2 autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies[J]. <i>Ann Neurol, <\/i>2013, 73(4): 449\u2013458.","DOI":"10.1002\/ana.23857"},{"key":"key-10.7555\/JBR.36.20220083-118","doi-asserted-by":"publisher","unstructured":"Sollvander S, Ekholm-Pettersson F, Brundin RM, et al.  Increased number of plasma B cells producing autoantibodies against A\u03b2<sub>42<\/sub> protofibrils in Alzheimer's disease[J]. <i>J Alzheimers Dis, <\/i>2015, 48(1): 63\u201372.","DOI":"10.3233\/JAD-150236"},{"key":"key-10.7555\/JBR.36.20220083-119","doi-asserted-by":"publisher","unstructured":"Maftei M, Thurm F, Schnack C, et al.  Increased levels of antigen-bound \u03b2-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients[J]. <i>PLoS One, <\/i>2013, 8(7): e68996.","DOI":"10.1371\/journal.pone.0068996"},{"key":"key-10.7555\/JBR.36.20220083-120","doi-asserted-by":"publisher","unstructured":"Mimouni D, Gdalevich M, Mimouni FB, et al.  Does immune serum globulin confer protection against skin diseases?[J]. <i>Int J Dermatol, <\/i>2000, 39(8): 628\u2013631.","DOI":"10.1046\/j.1365-4362.2000.00983.x"},{"key":"key-10.7555\/JBR.36.20220083-121","doi-asserted-by":"publisher","unstructured":"Bruhns P, Samuelsson A, Pollard JW, et al.  Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease[J]. <i>Immunity, <\/i>2003, 18(4): 573\u2013581.","DOI":"10.1016\/S1074-7613(03)00080-3"},{"key":"key-10.7555\/JBR.36.20220083-122","doi-asserted-by":"publisher","unstructured":"Siragam V, Crow AR, Brinc D, et al.  Intravenous immunoglobulin ameliorates ITP via activating Fc\u03b3 receptors on dendritic cells[J]. <i>Nat Med, <\/i>2006, 12(6): 688\u2013692.","DOI":"10.1038\/nm1416"},{"key":"key-10.7555\/JBR.36.20220083-123","doi-asserted-by":"publisher","unstructured":"Marsh SE, Abud EM, Lakatos A, et al.  The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function[J]. <i>Proc Natl Acad Sci U S A, <\/i>2016, 113(9): E1316\u2013E1325.","DOI":"10.1073\/pnas.1525466113"},{"key":"key-10.7555\/JBR.36.20220083-124","doi-asserted-by":"publisher","unstructured":"Cribbs DH, Berchtold NC, Perreau V, et al.  Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study[J]. <i>J Neuroinflammation, <\/i>2012, 9: 179.","DOI":"10.1186\/1742-2094-9-179"},{"key":"key-10.7555\/JBR.36.20220083-125","doi-asserted-by":"publisher","unstructured":"Pr\u00fcss H, H\u00f6ltje M, Maier N, et al.  IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment[J]. <i>Neurology, <\/i>2012, 78(22): 1743\u20131753.","DOI":"10.1212\/WNL.0b013e318258300d"},{"key":"key-10.7555\/JBR.36.20220083-126","doi-asserted-by":"publisher","unstructured":"Martin F, Chan AC.  B cell immunobiology in disease: evolving concepts from the clinic[J]. <i>Annu Rev Immunol, <\/i>2006, 24: 467\u2013496.","DOI":"10.1146\/annurev.immunol.24.021605.090517"},{"key":"key-10.7555\/JBR.36.20220083-127","doi-asserted-by":"publisher","unstructured":"Lanzavecchia A.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes[J]. <i>Annu Rev Immunol, <\/i>1990, 8: 773\u2013793.","DOI":"10.1146\/annurev.iy.08.040190.004013"},{"key":"key-10.7555\/JBR.36.20220083-128","doi-asserted-by":"publisher","unstructured":"Avalos AM, Ploegh HL.  Early BCR events and antigen capture, processing, and loading on MHC class II on B cells[J]. <i>Front Immunol, <\/i>2014, 5: 92.","DOI":"10.3389\/fimmu.2014.00092"},{"key":"key-10.7555\/JBR.36.20220083-129","doi-asserted-by":"publisher","unstructured":"Sonoda KH, Stein-Streilein J.  CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance[J]. <i>Eur J Immunol, <\/i>2002, 32(3): 848\u2013857.","DOI":"10.1002\/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I"},{"key":"key-10.7555\/JBR.36.20220083-130","doi-asserted-by":"publisher","unstructured":"Tomihara K, Shin T, Hurez VJ, et al.  Aging-associated B7-DC<sup>+<\/sup> B cells enhance anti-tumor immunity via Th1 and Th17 induction[J]. <i>Aging Cell, <\/i>2012, 11(1): 128\u2013138.","DOI":"10.1111\/j.1474-9726.2011.00764.x"},{"key":"key-10.7555\/JBR.36.20220083-131","doi-asserted-by":"publisher","unstructured":"Xiong L, Xue L, Du R, et al.  Single-cell RNA sequencing reveals B cell-related molecular biomarkers for Alzheimer's disease[J]. <i>Exp Mol Med, <\/i>2021, 53(12): 1888\u20131901.","DOI":"10.1038\/s12276-021-00714-8"},{"key":"key-10.7555\/JBR.36.20220083-132","doi-asserted-by":"publisher","unstructured":"Kim K, Wang X, Ragonnaud E, et al.  Therapeutic B-cell depletion reverses progression of Alzheimer's disease[J]. <i>Nat Commun, <\/i>2021, 12(1): 2185.","DOI":"10.1038\/s41467-021-22479-4"},{"key":"key-10.7555\/JBR.36.20220083-133","doi-asserted-by":"publisher","unstructured":"Weber MS, Prod'Homme T, Patarroyo JC, et al.  B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity[J]. <i>Ann Neurol, <\/i>2010, 68(3): 369\u2013383.","DOI":"10.1002\/ana.22081"},{"key":"key-10.7555\/JBR.36.20220083-134","doi-asserted-by":"publisher","unstructured":"Pierson ER, Stromnes IM, Goverman JM.  B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system[J]. <i>J Immunol, <\/i>2014, 192(3): 929\u2013939.","DOI":"10.4049\/jimmunol.1302171"},{"key":"key-10.7555\/JBR.36.20220083-135","doi-asserted-by":"publisher","unstructured":"Desmond DW, Moroney JT, Sano M, et al.  Incidence of dementia after ischemic stroke: results of a longitudinal study[J]. <i>Stroke, <\/i>2002, 33(9): 2254\u20132262.","DOI":"10.1161\/01.STR.0000028235.91778.95"},{"key":"key-10.7555\/JBR.36.20220083-136","doi-asserted-by":"publisher","unstructured":"Mena H, Cadavid D, Rushing EJ.  Human cerebral infarct: a proposed histopathologic classification based on 137 cases[J]. <i>Acta Neuropathol, <\/i>2004, 108(6): 524\u2013530.","DOI":"10.1007\/s00401-004-0918-z"},{"key":"key-10.7555\/JBR.36.20220083-137","doi-asserted-by":"publisher","unstructured":"Rosser EC, Mauri C.  Regulatory B cells: origin, phenotype, and function[J]. <i>Immunity, <\/i>2015, 42(4): 607\u2013612.","DOI":"10.1016\/j.immuni.2015.04.005"},{"key":"key-10.7555\/JBR.36.20220083-138","doi-asserted-by":"publisher","unstructured":"Olkhanud PB, Damdinsuren B, Bodogai M, et al.  Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4<sup>+<\/sup> T cells to T-regulatory cells[J]. <i>Cancer Res, <\/i>2011, 71(10): 3505\u20133515.","DOI":"10.1158\/0008-5472.CAN-10-4316"},{"key":"key-10.7555\/JBR.36.20220083-139","doi-asserted-by":"publisher","unstructured":"Minter MR, Main BS, Brody KM, et al.  Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response <i>in vitro<\/i>[J]. <i>J Neuroinflammation, <\/i>2015, 12: 71.","DOI":"10.1186\/s12974-015-0263-2"},{"key":"key-10.7555\/JBR.36.20220083-140","doi-asserted-by":"publisher","unstructured":"Bodogai M, Moritoh K, Lee-Chang C, et al.  Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells[J]. <i>Cancer Res, <\/i>2015, 75(17): 3456\u20133465.","DOI":"10.1158\/0008-5472.CAN-14-3077"},{"key":"key-10.7555\/JBR.36.20220083-141","doi-asserted-by":"publisher","unstructured":"Sun J, Flach CF, Czerkinsky C, et al.  B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit[J]. <i>J Immunol, <\/i>2008, 181(12): 8278\u20138287.","DOI":"10.4049\/jimmunol.181.12.8278"},{"key":"key-10.7555\/JBR.36.20220083-142","doi-asserted-by":"publisher","unstructured":"Shen P, Roch T, Lampropoulou V, et al.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases[J]. <i>Nature, <\/i>2014, 507(7492): 366\u2013370.","DOI":"10.1038\/nature12979"},{"key":"key-10.7555\/JBR.36.20220083-143","doi-asserted-by":"publisher","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, et al.  Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression[J]. <i>J Clin Invest, <\/i>2008, 118(10): 3420\u20133430.","DOI":"10.1172\/JCI36030"},{"key":"key-10.7555\/JBR.36.20220083-144","doi-asserted-by":"publisher","unstructured":"Collison LW, Chaturvedi V, Henderson AL, et al.  IL-35-mediated induction of a potent regulatory T cell population[J]. <i>Nat Immunol, <\/i>2010, 11(12): 1093\u20131101.","DOI":"10.1038\/ni.1952"},{"key":"key-10.7555\/JBR.36.20220083-145","doi-asserted-by":"publisher","unstructured":"Kurnellas MP, Ghosn EEB, Schartner JM, et al.  Amyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain disease[J]. <i>Proc Natl Acad Sci U S A, <\/i>2015, 112(49): 15016\u201315023.","DOI":"10.1073\/pnas.1521206112"},{"key":"key-10.7555\/JBR.36.20220083-146","doi-asserted-by":"publisher","unstructured":"Orgogozo JM, Gilman S, Dartigues JF, et al.  Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization[J]. <i>Neurology, <\/i>2003, 61(1): 46\u201354.","DOI":"10.1212\/01.WNL.0000073623.84147.A8"},{"key":"key-10.7555\/JBR.36.20220083-147","doi-asserted-by":"publisher","unstructured":"Nicoll JAR, Wilkinson D, Holmes C, et al.  Neuropathology of human Alzheimer disease after immunization with amyloid-\u03b2 peptide: a case report[J]. <i>Nat Med, <\/i>2003, 9(4): 448\u2013452.","DOI":"10.1038\/nm840"},{"key":"key-10.7555\/JBR.36.20220083-148","doi-asserted-by":"publisher","unstructured":"Saresella M, Calabrese E, Marventano I, et al.  A potential role for the PD1\/PD-L1 pathway in the neuroinflammation of Alzheimer's disease[J]. <i>Neurobiol Aging, <\/i>2012, 33(3): 624.e11\u2013624.e22.","DOI":"10.1016\/j.neurobiolaging.2011.03.004"},{"key":"key-10.7555\/JBR.36.20220083-149","doi-asserted-by":"publisher","unstructured":"Baruch K, Deczkowska A, Rosenzweig N, et al.  PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease[J]. <i>Nat Med, <\/i>2016, 22(2): 135\u2013137.","DOI":"10.1038\/nm.4022"},{"key":"key-10.7555\/JBR.36.20220083-150","doi-asserted-by":"publisher","unstructured":"Rosenzweig N, Dvir-Szternfeld R, Tsitsou-Kampeli A, et al.  PD-1\/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model[J]. <i>Nat Commun, <\/i>2019, 10(1): 465.","DOI":"10.1038\/s41467-019-08352-5"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.36.20220083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:31:41Z","timestamp":1684110701000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.36.20220083?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["JBR-2022-0083"],"URL":"https:\/\/doi.org\/10.7555\/jbr.36.20220083","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}